Genomic sequencing has progressed so rapidly that researchers can now analyze the genetic profiles of healthy individuals to uncover mutations that will almost certainly lead to a genetic condition. These breakthroughs are demonstrating that the future of genomic medicine will focus not just on the ability to reactively treat diseases, but on predicting and preventing them before they occur.
In this video from SC16, Steve Conway from IDC moderates a panel discussion on Precision Medicine. “Recently, DOE Secretary Moniz, VA Secretary MacDonald, NCI Director Lowy and the GSK CEO Andrew Witty announced that the Nation’s leading supercomputers would be applied to the challenge of the Cancer Moonshot initiative. This partnership of nontraditional groups, collectively see the path to unraveling the complexities of cancer through the power of new machines, operating systems, and applications that leverage simulations, data science and artificial intelligence to accelerate bringing precision oncology to the patients that are waiting. This initiative is one of many research efforts in the race to solve some of our most challenging medical problems.”
A panel of some of the world’s leading experts will come together to discuss this next frontier of healthcare at SC16, the premier international conference showcasing HPC on Nov. 14 in Salt Lake City. “Truly transformative discoveries are happening, and those discoveries are driving powerful shifts in how we combat disease and make people’s lives better.”
In this video, Dr. Dimitri Kusnezov from the U.S. Department of Energy National Nuclear Security Administration presents: Supercomputing the Cancer Moonshot and Beyond. “How can the next generation of supercomputers unlock biomedical mysteries that will shape the future practice of medicine? Scientists behind the National Strategic Computing Initiative, a federal strategy for investing in high-performance computing, are exploring this question.”
Today the PASC17 Conference announced a track focused on Precision Medicine as Special Topic for Emerging Domains. “Precision medicine, also referred to as personalized medicine, is an emerging domain that is adding tremendous value to the study of life sciences and medical treatment. The requirements that it has for rapid – and secure – processing, analysis and management of vast quantities of data in a wide range of different medical environments make precision medicine ideally suited to high performance computing.”
SC16 will continue its HPC Matters Plenary session series this year with a panel discussion on HPC and Precision Medicine. The event will take place at 5:30 pm on Monday, Nov 14 just prior to the exhibits opening gala. “The success of all of these research programs hinge on harnessing the power of HPC to analyze volumes of complex genomics and other biological datasets that simply can’t be processed by humans alone. The challenge for our community will be to develop the computing tools and services needed to transform how we think about disease and bring us closer to the precision medicine future.”